This article needs additional citations for verification. Please help improve this articlebyadding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Rolitetracycline" – news · newspapers · books · scholar · JSTOR (December 2014) (Learn how and when to remove this message) |
Clinical data | |
---|---|
Other names | (2Z,4S,4aS,5aS,6S,12aS)-4-Dimethylamino-6,10,11,12a-tetrahydroxy-2-[hydroxy-(pyrrolidin-1-ylmethylamino)methylidene]-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione |
ATC code | |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.010.938 |
Chemical and physical data | |
Formula | C27H33N3O8 |
Molar mass | 527.574 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Rolitetracycline is a tetracycline antibiotic.[1] Tetracycline is N-Mannich base prodrug that is prepared from tetracycline by condensation with pyrrolidine and formaldehyde to produce rolitetracycline. Rolitetracycline is used as an antibacterial drug, a protein synthesis inhibitor, an antiprotozoal drug and a prodrug.[2][3]
| |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
30S |
| ||||||||||||||
50S |
| ||||||||||||||
EF-G |
| ||||||||||||||
|
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |